109 related articles for article (PubMed ID: 23339165)
1. Sex-specific mTOR signaling determines sexual dimorphism in myocardial adaptation in normotensive DOCA-salt model.
Gürgen D; Kusch A; Klewitz R; Hoff U; Catar R; Hegner B; Kintscher U; Luft FC; Dragun D
Hypertension; 2013 Mar; 61(3):730-6. PubMed ID: 23339165
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor-beta signals left ventricular hypertrophy sex differences in normotensive deoxycorticosterone acetate-salt mice.
Gürgen D; Hegner B; Kusch A; Catar R; Chaykovska L; Hoff U; Gross V; Slowinski T; da Costa Goncalves AC; Kintscher U; Gustafsson JÅ; Luft FC; Dragun D
Hypertension; 2011 Mar; 57(3):648-54. PubMed ID: 21300662
[TBL] [Abstract][Full Text] [Related]
3. 17ß-Estradiol regulates mTORC2 sensitivity to rapamycin in adaptive cardiac remodeling.
Kusch A; Schmidt M; Gürgen D; Postpieszala D; Catar R; Hegner B; Davidson MM; Mahmoodzadeh S; Dragun D
PLoS One; 2015; 10(4):e0123385. PubMed ID: 25880554
[TBL] [Abstract][Full Text] [Related]
4. Deoxycorticosterone acetate-salt mice exhibit blood pressure-independent sexual dimorphism.
Karatas A; Hegner B; de Windt LJ; Luft FC; Schubert C; Gross V; Akashi YJ; Gürgen D; Kintscher U; da Costa Goncalves AC; Regitz-Zagrosek V; Dragun D
Hypertension; 2008 Apr; 51(4):1177-83. PubMed ID: 18259006
[TBL] [Abstract][Full Text] [Related]
5. Impact of salt on cardiac differential gene expression and coronary lesion in normotensive mineralocorticoid-treated mice.
Wang Q; Domenighetti AA; Schäfer SC; Weber J; Simon A; Maillard MP; Pedrazzini T; Chen J; Lehr HA; Burnier M
Am J Physiol Regul Integr Comp Physiol; 2012 May; 302(9):R1025-33. PubMed ID: 22403797
[TBL] [Abstract][Full Text] [Related]
6. Sex differences in exercise-induced physiological myocardial hypertrophy are modulated by oestrogen receptor beta.
Dworatzek E; Mahmoodzadeh S; Schubert C; Westphal C; Leber J; Kusch A; Kararigas G; Fliegner D; Moulin M; Ventura-Clapier R; Gustafsson JA; Davidson MM; Dragun D; Regitz-Zagrosek V
Cardiovasc Res; 2014 Jun; 102(3):418-28. PubMed ID: 24654233
[TBL] [Abstract][Full Text] [Related]
7. Lack of inducible NO synthase reduces oxidative stress and enhances cardiac response to isoproterenol in mice with deoxycorticosterone acetate-salt hypertension.
Sun Y; Carretero OA; Xu J; Rhaleb NE; Wang F; Lin C; Yang JJ; Pagano PJ; Yang XP
Hypertension; 2005 Dec; 46(6):1355-61. PubMed ID: 16286571
[TBL] [Abstract][Full Text] [Related]
8. Cardiac mTOR complex 2 preserves ventricular function in pressure-overload hypertrophy.
Shende P; Xu L; Morandi C; Pentassuglia L; Heim P; Lebboukh S; Berthonneche C; Pedrazzini T; Kaufmann BA; Hall MN; Rüegg MA; Brink M
Cardiovasc Res; 2016 Jan; 109(1):103-14. PubMed ID: 26598511
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological Inhibition of Mammalian Target of Rapamycin Attenuates Deoxycorticosterone Acetate Salt-Induced Hypertension and Related Pathophysiology: Regulation of Oxidative Stress, Inflammation, and Cardiovascular Hypertrophy in Male Rats.
Temiz-Resitoglu M; Guden DS; Senol SP; Vezir O; Sucu N; Kibar D; Yılmaz SN; Tunctan B; Malik KU; Sahan-Firat S
J Cardiovasc Pharmacol; 2022 Mar; 79(3):355-367. PubMed ID: 34840266
[TBL] [Abstract][Full Text] [Related]
10. Induction of hypertension and cardiac hypertrophy in guinea pig by DOCA salt.
Tiritilli A; Ruff F
Methods Find Exp Clin Pharmacol; 1994; 16(6):391-6. PubMed ID: 7837830
[TBL] [Abstract][Full Text] [Related]
11. Sex- and tissue-specific changes in mTOR signaling with age in C57BL/6J mice.
Baar EL; Carbajal KA; Ong IM; Lamming DW
Aging Cell; 2016 Feb; 15(1):155-66. PubMed ID: 26695882
[TBL] [Abstract][Full Text] [Related]
12. Involvement of the endothelin ET(B) receptor in gender differences in deoxycorticosterone acetate-salt-induced hypertension.
Kawanishi H; Hasegawa Y; Nakano D; Ohkita M; Takaoka M; Ohno Y; Matsumura Y
Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):280-5. PubMed ID: 17324138
[TBL] [Abstract][Full Text] [Related]
13. Cardiac sympathetic hyperinnervation in deoxycorticosterone acetate-salt hypertensive rats.
Lee TM; Chen CC; Chang NC
Clin Sci (Lond); 2012 Oct; 123(7):445-57. PubMed ID: 22507072
[TBL] [Abstract][Full Text] [Related]
14. Genetic ablation and pharmacological inhibition of immunosubunit β5i attenuates cardiac remodeling in deoxycorticosterone-acetate (DOCA)-salt hypertensive mice.
Cao HJ; Fang J; Zhang YL; Zou LX; Han X; Yang J; Yan X; Li PB; Wang HX; Guo SB; Li HH
J Mol Cell Cardiol; 2019 Dec; 137():34-45. PubMed ID: 31629736
[TBL] [Abstract][Full Text] [Related]
15. Cardiac Ablation of SOCS3 Aggravates DOCA-Salt-Induced Hypertrophic Remodeling by Activation of Gp130-Dependent Signaling in Mice.
Liu S; Liu LX; Zhang YL; Lai S; Xie YP; Li NN; Wang HX; Xia YL; Liu Y; Li HH
Cell Physiol Biochem; 2018; 47(1):140-150. PubMed ID: 29763909
[TBL] [Abstract][Full Text] [Related]
16. Mineralocorticoid signaling in transition to heart failure with normal ejection fraction.
Shapiro BP; Owan TE; Mohammed S; Kruger M; Linke WA; Burnett JC; Redfield MM
Hypertension; 2008 Feb; 51(2):289-95. PubMed ID: 18086943
[TBL] [Abstract][Full Text] [Related]
17. Baicalein attenuates angiotensin II-induced cardiac remodeling via inhibition of AKT/mTOR, ERK1/2, NF-κB, and calcineurin signaling pathways in mice.
Wang AW; Song L; Miao J; Wang HX; Tian C; Jiang X; Han QY; Yu L; Liu Y; Du J; Xia YL; Li HH
Am J Hypertens; 2015 Apr; 28(4):518-26. PubMed ID: 25362112
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Suppression of mTOR (Mammalian Target of Rapamycin) Signaling Prevents and Reverses Salt-Induced Hypertension and Kidney Injury in Dahl Salt-Sensitive Rats.
Kumar V; Evans LC; Kurth T; Yang C; Wollner C; Nasci V; Zheleznova NN; Bukowy J; Dayton A; Cowley AW
Hypertension; 2019 Mar; 73(3):630-639. PubMed ID: 30595123
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of inflammation and fibrosis by a complement C5a receptor antagonist in DOCA-salt hypertensive rats.
Iyer A; Woodruff TM; Wu MC; Stylianou C; Reid RC; Fairlie DP; Taylor SM; Brown L
J Cardiovasc Pharmacol; 2011 Nov; 58(5):479-86. PubMed ID: 21753735
[TBL] [Abstract][Full Text] [Related]
20. mTOR inhibitor improves testosterone-induced myocardial hypertrophy in hypertensive rats.
Chen J; Yu J; Yuan R; Li N; Li C; Zhang X
J Endocrinol; 2022 Jan; 252(3):179-193. PubMed ID: 34874016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
